🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is an open-label Phase 1 single dose-escalation safety study of C...
Status
Completed
Location
Mayo Clinic Florida
Start Date
2018-10-15
Trial ID
NCT03464916
Treatments Being Tested
Considerable progress in the treatment of metastatic melanoma has been made...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2015-10
Trial ID
NCT02619058
Treatments Being Tested
The primary purpose of this study is to determine the safety and efficacy o...
Status
Unknown
Location
The Affiliated People's Hospital of Ningbo University
Start Date
2021-09-16
Trial ID
NCT05528887
Treatments Being Tested
This screening study is intended for men and women ≥ 18 to ≤ 75 years of ag...
Status
Completed
Location
City of Hope
Start Date
2015-12
Trial ID
NCT02636855
Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Status
Unknown
Location
Hospital Maissoneuve
Start Date
2016-03
Trial ID
NCT02519816
Phase I study to establish safety and feasibility of intravenously administ...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2014-06
Trial ID
NCT02159716
Treatments Being Tested
RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Status
Unknown
Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
Start Date
2015-10
Trial ID
NCT02580747
Treatments Being Tested
This research study is being carried out to study a new way to possibly tre...
Status
Active Not Recruiting
Location
University of Pennsylvania
Start Date
2019-07-31
Trial ID
NCT03617198
Treatments Being Tested
RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Status
Completed
Location
Knight Cancer Institute at Oregon Health and Science University
Start Date
2005-03
Trial ID
NCT00238433
The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Status
Terminated
Location
University of California, San Francisco
Start Date
2015-08-27
Trial ID
NCT02428309
Treatments Being Tested